Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $640.6000 (4.28%) ($612.2000 - $644.3400) on Tue. Jul. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.76% (three month average) | RSI | 53 | Latest Price | $640.6000(4.28%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN advances 1.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) SPLV(39%) IVW(38%) IWF(37%) | Factors Impacting REGN price | REGN will decline at least -1.38% in a week (0% probabilities). VIXM(-21%) VXX(-7%) UUP(-7%) TBT(-6%) IYT(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.38% (StdDev 2.76%) | Hourly BBV | 2.1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $631.17(1.49%) | 10 Day Moving Average | $627.93(2.02%) | 20 Day Moving Average | $621.36(3.1%) | To recent high | -0.4% | To recent low | 25.1% | Market Cap | $67.922b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |